Metraipolis › archive › dc_22c674fa9e10
Berberine signature and cardiometabolic diseases using randomized controlled trial, cohort study and Mendelian randomization — Europe PMC PMID:41882153
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41882153
- DOI
- 10.1038/s44325-[numero omesso]-w
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T23:20:01.029Z
- SHA-256 of the archived text
0e114b10ed75e5ad302b0443d735f2f7338d18bc358f88d3b5170c2ea1df8a49- Stable URL of this page
https://metraipolis.com/documento/dc_22c674fa9e10
How to cite
Berberine signature and cardiometabolic diseases using randomized controlled trial, cohort study and Mendelian randomization — Europe PMC PMID:41882153 — Europe PMC (en), https://europepmc.org/article/MED/41882153 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_22c674fa9e10 (Metraipolis archive dc_22c674fa9e10, sha256 0e114b10ed75e5ad302b0443d735f2f7338d18bc358f88d3b5170c2ea1df8a49)
BibTeX
@misc{dc22c674fa9e10,
title = {Berberine signature and cardiometabolic diseases using randomized controlled trial, cohort study and Mendelian randomization — Europe PMC PMID:41882153},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41882153},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_22c674fa9e10; sha256 0e114b10ed75e5ad302b0443d735f2f7338d18bc358f88d3b5170c2ea1df8a49},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41882153. Agents can read the archived copy with the MCP tool read_document.